News | October 10, 2007

62 Percent of Cancer Patients Who Suspected They Had Cancer Not Diagnosed

October 11, 2007 — According to the results of a survey, "Cancer and the Public," 62 percent of the 32 percent of cancer patients who suspected they had cancer, were not diagnosed for three months or more.
In addition, nearly half of the respondents did not feel that their insurance coverage would provide adequate care if diagnosed with a life threatening illness. The total number of respondents to the survey was 4,402, (1,779 males and 2,623 females) representing every state in the U.S.
Among the findings of the survey, which was prepared by The Tower Cancer Research Foundation were:
- 79 percent of respondents said people feared cancer the most.
- Of the 32 percent of cancer victims who suspected they had cancer before being diagnosed, 42 percent did not get diagnosed for six months or longer, 21 percent did not get diagnosed for one year or longer and 9 percent did not get diagnosed for up to two years.

For more information: www.towercancerfoundation.org

Related Content

MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...
cancer immunotherapy, development, Axel Hoos, Nature Reviews, imaging
News | Oncology Related Products | March 31, 2016
In a paper published in Nature Reviews last week, Axel Hoos, M.D., Ph.D., laid out the current immunotherapy...
Pyrexar, buy back outside ownership, Person Medical, BSD-2000 Hyperthermia System

BSD-2000 image courtesy of Pyrexar Medical

News | Oncology Related Products | March 15, 2016
Pyrexar announced it has purchased back outside ownership from Person Medical (formerly BSD Medical), concluding a...
BTG, LC Bead LUMI, radiopaque embolic bead, Philips Healthcare, Live Image Guidance, liver cancer
News | Interventional Radiology | February 09, 2016
BTG plc and Royal Philips announced a significant milestone in their collaboration with the treatment of the first...
Overlay Init